“Efficacy and Safety of Evobrutinib in Relapsing Multiple Sclerosis: A Systematic Review of Randomized Controlled Trials”. 2025. Magna Neurologica 3 (2): 138-49. https://doi.org/10.20961/magnaneurologica.v3i2.1929.